NeuroWebinars

About

ECTRIMS NeuroWebinars facilitate connectivity and enable the professional MS community to elevate topics of interest, navigate discussions around clinical research & practice, and drive the exposure and development of ideas and innovation. Our aim is to help build a community where participants are given their “own space” to share and present new research, insights and ideas.

De-escalation & Discontinuation of DMTs – Why, When and How?

12 June 2024

Our expert panel discusses a critical aspect of MS management: the de-escalation and discontinuation of DMTs.

Cutting-edge discussions on MS therapies: high efficacy DMTs and more

6 May 2024

Our expert panel will discuss the latest advancements in MS therapies, including high efficacy DMTs and beyond.

Exploring Ageing and Multiple Sclerosis

30 April 2024

This webinar explores outcomes from a recent international workshop on Ageing in MS convened by the International Advisory Committee on Clinical Trials in MS.

Pregnancy Treatment & Therapies for MS, NMOSD & MOGAD

8 March 2024

This webinar focuses on the often under-explored considerations and options for managing MS, NMOSD and MOGAD during pregnancy.

Accessing MS Treatment for All - An Update

14 Feb 2024

Experts deep dive into the efforts led by MSIF to secure the inclusion of essential MS medications in the WHO's Essential Medicines List.

Understanding PIRA in Multiple Sclerosis

31 May 2023

Leading experts guide participants through the complex web of PIRA research and discuss the possible implications for future practice.

High-Efficacy Therapies in MS Treatment

10 May 2023

MS experts discuss factors associated with high-efficacy treatment outcomes, from severity at diagnosis & initiation timing, to previous treatments & vaccination status.